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published September 21, 2010; doi:10.1152/ajpendo.00431.2010.—Li-
poprotein-associated cholesterol has been suggested to make a signif-
icant contribution to adrenal steroidogenesis in vivo. To determine
whether lipoproteins indeed contribute to optimal adrenal steroido-
genesis in mice, in the current study we have determined the effect of
relative lipoprotein deficiency on adrenal steroidogenesis in C57BL/6
wild-type mice. Feeding C57BL/6 mice the lipid-lowering drug pro-
bucol (0.25% wt/wt) for 2 wk induced a 90% decrease in plasma
high-density lipoprotein (HDL) cholesterol levels and a 77% reduc-
tion in low-density lipoprotein (LDL) cholesterol levels. Neutral lipid
stores were depleted upon probucol treatment specifically in the
glucocorticoid-producing zona fasciculata of the adrenal, leading to a
44% decreased plasma corticosterone level under basal conditions.
Exposure to lipopolysaccharide (LPS) induced a 37% increase in the
adrenal uptake of HDL cholesteryl esters. Probucol-treated mice could
induce only a relatively minor corticosterone response upon a LPS
challenge compared with controls, which coincided with an approx-
imately twofold increased hepatic expression level of interleukin-6
and tumor necrosis factor (TNF) and an 89% higher TNF response
in plasma. Furthermore, a compensatory two- to fivefold upregulation
of LDL receptor (cholesterol uptake) and HMG-CoA reductase (cho-
lesterol synthesis) expression was noticed in the adrenals of probucol-
treated mice. In conclusion, we have shown that lipoprotein deficiency
in mice as a result of probucol feeding is associated with decreased
adrenal cortex cholesterol levels, a lower basal and stress-induced
plasma glucocorticoid level, and an increased susceptibility to LPS-
induced inflammation. Therefore, it is suggested that plasma lipopro-
teins are required for optimal adrenal steroidogenesis and protection
against endotoxemia in mice.
probucol; scavenger receptor BI; low-density lipoprotein receptor;
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STEROID HORMONES CONSTITUTE A CLASS OF HORMONES that are
derived from cholesterol. They regulate a vast number of
physiological processes such as growth and metabolism. Ste-
roid hormones include the sex hormones testosterone and
estrogen as well as glucocorticoids and mineralocorticoids that
are secreted by the adrenals. A constant supply of cholesterol
is required within adrenal cells to serve as a precursor for the
conversion to glucocorticoids and mineralocorticoids. The
rate-limiting step for corticoid synthesis is the transport of
unesterified cholesterol from the outer mitochondrial mem-
brane to the inner membrane by steroidogenic acute regulatory
protein (StAR) (6, 7, 18). However, in response to a stressful
lifestyle, subjects can exhibit a sustained increase in plasma
glucocorticoid (i.e., cortisol) levels, which requires relatively
large amounts of cholesterol to be used for steroidogenesis
within the adrenals. Theoretically, the unesterified cholesterol
needed for optimal adrenal steroidogenesis under stress condi-
tions can be derived from several different sources: 1) de novo
synthesis of cholesterol from acetyl-CoA, 2) intracellular ca-
tabolism of stored cholesteryl esters, and 3) uptake of extra-
cellular cholesterol from lipoproteins [reviewed by Kraemer
(13)]. The relative contribution of these three pathways to basal
and stress-induced steroidogenesis has been studied exten-
sively in adrenocortical cells in vitro. The production of glu-
cocorticoids in cultured bovine adrenocortical cells is depen-
dent on the de novo synthesis of cholesterol, since pharmaco-
logical inhibition of hydroxylmethylglutaryl (HMG)-CoA reductase
activity significantly impairs both basal and adrenocortico-
tropic hormone (ACTH)-stimulated cortisol secretion (24). In
addition, the breakdown of cholesteryl esters to free cholesterol
by hormone-sensitive lipase (HSL) is also of quantitative
importance for adrenal glucocorticoid synthesis since HSL
deficiency is associated with a significantly lower basal and
stimulated corticosterone production in mouse adrenocortical
cells in vitro (14). Importantly, already in the 1950s it was
shown that 95% of the adrenal cholesterol pool in rats does
not originate from local sources (i.e., de novo synthesis or
cellular catabolism) but rather from the plasma compartment
(21). Although cholesterol is also an important building block
for cell membranes, this finding does clearly suggest that
lipoprotein-associated cholesterol may also make a significant
contribution to adrenal steroidogenesis in vivo. To determine
whether lipoproteins indeed contribute to optimal adrenal ste-
roidogenesis in mice, in the current study we have determined
the effect of relative lipoprotein (i.e., LDL and HDL) defi-
ciency on basal and stress-induced glucocorticoid secretion by
the adrenals in C57BL/6 wild-type mice.
MATERIALS AND METHODS
Animals. Female C57BL/6 wild-type mice were obtained from the
Jackson Laboratory and fed a sterilized regular chow powder diet
(RM3; Special Diet Services, Witham, UK) with or without 0.25%
(wt/wt) probucol (Sigma) supplementation. Mice were maintained on
a standardized light-dark cycle and were handled regularly and in an
identical manner prior to and during the experiment. Animal experi-
ments were performed at the Gorlaeus Laboratories of the Leiden/
Amsterdam Center for Drug Research in accordance with the national
laws. All experimental protocols were approved by the Ethics Com-
mittee for Animal Experiments of the Leiden University.
Lipid analyses. The distribution of cholesterol over the different
lipoproteins in plasma was analyzed by fractionation of 30 l of
plasma of each mouse using a Superose 6 column (3.2  300 mm,
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Smart-System; Pharmacia). Total cholesterol content of the effluent
was determined using enzymatic colorimetric assays (Roche Diagnos-
tics). Seven-micrometer cryosections of snap-frozen adrenals were
prepared on a Leica CM3050-S cryostat. Cryosections were routinely
stained with hematoxylin (Sigma) for nuclei and Oil Red O (Sigma)
for lipid visualization. Images were obtained with a Leica image
analysis system consisting of a Leica DMRE microscope coupled to a
camera and Leica Qwin Imaging software (Leica, Cambridge, UK).
Analysis of gene expression by real-time quantitative PCR. Quan-
titative gene expression was performed using real-time SYBR Green
technology (Eurogentec). Primers were validated for identical effi-
ciencies [slope  3.3 for a plot of threshold cycle (CT) vs. log ng
cDNA]. Primer sequences are available on request. Hypoxanthine
guanine phosphoribosyl transferase (HPRT), glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH), -actin, and acidic ribosomal phos-
phoprotein P0 (36B4) were used as the standard housekeeping genes.
Relative gene expression numbers were calculated by subtracting the
CT number of the target gene from the average CT of HPRT, GAPDH,
-actin, and 36B4 (CT housekeeping) and raising 2 to the power of
this difference. The average CT of four housekeeping genes was used
to exclude that changes in the relative expression were caused by
variations in the expression of the separate housekeeping genes.
Corticosterone and TNF response upon a lipopolysaccharide
challenge. Blood was drawn between 0800 and 0900 via tail cut using
a mouse restrainer for basal “nonstressed” plasma values of cortico-
sterone and TNF levels. Subsequently, mice were intravenously
injected at 0900 with a sublethal dose of 50 g/kg lipopolysaccharide
(LPS) from Salmonella Minnesota R595 (List Biological Laborato-
ries, Hornby, ON, Canada) into the tail vein. At the indicated times
following LPS injection, tail cut blood samples were collected and
plasma corticosterone and TNF levels determined by [125I]radioim-
munoassay (RIA) from MP Biomedicals (Irvine, CA) and ELISA
(OptEIA kit; BD Biosciences Pharmingen, San Diego, CA), respec-
tively.
Tissue uptake of [3H]cholesteryl ether HDL. Human HDL was
isolated from blood of healthy subjects by differential ultracentrifugation
and dialyzed against PBS with 1 mM EDTA. HDL (1.063  d  1.21)
was labeled with [3H]cholesteryl ether (CEt) via exchange from donor
particles. A dose of 200 g of apolipoprotein (	1.2  106 dpm) of
[3H]HDL-CEt (total volume 100 l) was injected into the tail vein. For
analysis of tissue cholesteryl ether uptake, 2 h after tracer injection tissues
were excised, weighed, solubilized, and counted for [3H]radioactivity in
a Packard liquid scintillation unit. A correction was made for the radio-
activity in the blood present in the tissues at the time of sampling. Values
were expressed as percent of the injected dose per microgram of tissue.
To determine the effect of LPS on the tissue uptake of [3H]HDL-CEt,
mice were preinjected with 50 g/kg LPS 1 h before injection of the
[3H]HDL-CEt.
Data analysis. Statistical analyses were performed using two-tailed
unpaired t-test or two-way ANOVA, using Graphpad Prism Software
(http://www.graphpad.com; Graphpad Software, San Diego, CA).
Normality testing of the experimental groups was performed using the
method of Kolmogorov and Smirnov (Graphpad Instat Software). P 
0.05 was considered significant.
RESULTS
To induce an acute and short-term depletion of plasma
lipoproteins, C57BL/6 mice were fed a regular chow control
diet or a chow diet supplemented with the lipid-lowering drug
probucol for 2 wk. As anticipated, treatment with probucol
induced a marked decrease in plasma total cholesterol (89%,
P  0.001) and phospholipid (71%, P  0.001) levels in ad
libitum-fed mice (Table 1). Lipoprotein distribution analysis
revealed that the decrease in the plasma total cholesterol level
upon probucol treatment could be attributed to an 87% de-
crease in HDL cholesterol levels and a 77% decrease in LDL
cholesterol levels (Fig. 1). VLDL/chylomicron cholesterol levels
were unchanged after probucol treatment (Fig. 1). In parallel, no
significant difference was detected in plasma triglyceride levels
between probucol-fed and control-fed mice (Table 1).
Strikingly, the gross appearance of the adrenals was mark-
edly different between probucol-treated mice and control mice.
Although we did not observe a difference in weight of the
adrenals (Table 1), adrenals of probucol-treated mice appeared
darker (more red) compared with those of controls (Fig. 2A). In
parallel, a significant 54% decrease (P  0.0015) in total
adrenal cholesterol stores was observed upon probucol treat-
ment (Table 1). Oil Red O staining revealed that the neutral
lipid (i.e., cholesteryl ester) content of the adrenal cortex was
clearly decreased in probucol-fed mice compared with control-
fed mice. In particular, a decrease in Oil Red O-positive neutral
lipid stores was detected in the zona fasciculata, the area of the
adrenal cortex that contains the glucocorticoid-producing cells,
whereas the lipid content of mineralocorticoid-producing zona
glomerulosa seemed to be essentially unaffected (Fig. 2B).
Importantly, a significant decrease in the plasma corticoste-
rone levels was noted in probucol-treated mice under basal
nonstressed conditions (P  0.016; Fig. 3A). In the adrenals,
probucol did not affect the relative gene expression level of
Table 1. Plasma and adrenal lipid levels in probucol-treated
and control mice
Parameter Control Probucol P Value
Body weight, g 17.8 	 0.5 17.8 	 0.7 1.00
Plasma
Total cholesterol, mg/dl 58 	 2 6.5 	 0.3 0.001
Phospholipid, mg/dl 136 	 6 39 	 1 0.001
Triglyceride, mg/dl 57 	 9 39 	 3 0.11
Adrenals
Weight, mg 6.4 	 1.1 6.2 	 0.8 0.90
Weight, %BW 0.036 	 0.006 0.035 	 0.005 0.94
Total cholesterol, g/mg
protein
17 	 1 8 	 1 0.0015
Data represent means 	 SE of 5 mice. %BW, percentage of body weight.
Fig. 1. The effect of probucol on the plasma lipoprotein cholesterol distribu-
tion. Blood samples were drawn from mice fed a regular chow diet (Œ) or a diet
supplemented with 0.25% probucol () for 2 wk. Pooled plasma from 5 mice
was loaded onto a Superose 6 column, and fractions were collected. Fractions
3–7 represent VLDL, fractions 8–13 represent LDL, and fractions 14–20
represent HDL.
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StAR (Fig. 3B), the rate-limiting factor for acute adrenal
steroidogenesis. In addition, no significant change was ob-
served in the mRNA expression level of cytochrome P450scc
(CYP11A1; Fig. 3B) that catalyzes the first and rate-limiting
step in the biosynthesis of hormones in all steroidogenic
tissues, namely the conversion of cholesterol to pregnenolone.
Furthermore, no significant change in the relative mRNA
expression level of the HDL receptor scavenger receptor BI
(SR-BI), the LDL receptor, HSL, or acyl-coenzyme A:choles-
terol acyltransferase-1 (ACAT1) was observed (Fig. 3B), sug-
gesting that the activity of lipoprotein uptake as well as
intracellular cholesterol ester synthesis and catabolism systems
was unaltered by probucol treatment. In contrast, probucol
treatment significantly increased the adrenal relative expres-
sion level of HMG-CoA reductase (
47%, P  0.036; Fig.
3B). This suggests a compensatory stimulation of the rate of
cholesterol synthesis from acetyl-CoA in response to probucol
treatment. Thus it seems that the decrease in the basal adrenal
glucocorticoid synthesis rate after probucol feeding was not
due to a change in the expression level of essential steroido-
genic enzymes but more likely due to impaired substrate
(unesterified cholesterol) availability.
The liver is a key target organ of glucocorticoids, since via
the action of the nuclear glucocorticoid receptor they are able
to modulate the hepatic expression of genes involved in glu-
cose, cholesterol, and bile acid metabolism (5, 27). Probucol
did not change the expression of the glucocorticoid-responsive
genes apolipoprotein A4 and cholesterol 7-hydroxylase under
basal feeding (nonstressed) conditions (Fig. 3C). This suggests
that the decrease in plasma corticosterone levels upon probucol
treatment was not associated with a concomitant change in
hepatic glucocorticoid receptor activity under basal conditions.
As a first-line defense protective “stress” response to over-
come inflammation-associated morbidity (i.e., sepsis) and mor-
tality, adrenals readily secrete high levels of anti-inflammatory
glucocorticoids upon exposure to LPS. To investigate the
effect of probucol on the adrenal response to stress, probucol-
fed and chow-fed mice were therefore exposed to a sublethal
dose of LPS. As anticipated, exposure to LPS induced a rapid
time-dependent increase in plasma corticosterone levels in
control-treated mice (Fig. 4A). In probucol-fed mice, an acute
rise in plasma corticosterone levels also occurred within the
first hour after the injection with LPS. Subsequently, however,
the plasma corticosterone concentration did not increase fur-
ther and actually declined gradually in the probucol-treated
mice, resulting in a fourfold lower (P  0.001) plasma corti-
costerone level 3 h after the LPS injection and a significantly
decreased overall corticosterone response compared with con-
trol-treated mice (P  0.001; Fig. 4A). Thus it seems that
probucol has no major effect on the “acute” (1 h) steroido-
genesis but does impair the “sustained” adrenal corticosterone
response to stress.
The initial response of adrenocortical cells to stress (i.e.,
ACTH stimulation) is an increase in cholesterol esterase activ-
Fig. 2. The effect of probucol treatment on the
gross morphology of the adrenals (A) and adrenal
cortex lipid levels (B). Note the clear darkening of
the adrenals in probucol-fed mice. Cryosections of
adrenals were stained with Oil Red O for neutral
lipids and counterstained with hematoxylin for nu-
clei. ZG, zona glomerulosa; ZF, zona fasciculata.
Fig. 3. The effect of probucol treatment on the plasma corticosterone level (A), the adrenal relative mRNA expression levels of steroidogenic acute regulatory
protein (StAR), cytochrome P450scc (CYP11A1), scavenger receptor BI (SR-BI), the LDL receptor (LDLR), hydroxymethylglutaryl-CoA reductase (HMGCR),
hormone-sensitive lipase (HSL), and acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT1) (B), and the hepatic relative mRNA expression levels of
glucocorticoid-responsive genes cholesterol 7-hydroxylase (CYP7A1) and apolipoprotein A4 (apoA4) under basal “nonstressed” conditions (C). Data represent
means 	 SE of 5–10 mice. *P  0.05 compared with controls.
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ity, presumably reflecting the physiological purpose of having
a readily accessible store of substrate for steroidogenesis (25).
Also, upon LPS exposure, no change in the mRNA expression
level of cholesteryl ester synthesis (ACAT1) or catabolism
(HSL) genes was observed between probucol-fed and control
mice (Fig. 4B). However, we detected a 2.4- and 5.3-fold
increase (P  0.001 for both) in the adrenal relative mRNA
expression of the LDL receptor and HMG-CoA reductase from
probucol-fed mice compared with control-fed mice under high
steroidogenic pressure conditions (Fig. 4B). This suggests a
compensatory upregulation of a cholesterol delivery route by
the LDL receptor and an increased cholesterol synthesis by
HMG-CoA reductase in mice that exhibit relative lipoprotein
deficiency in response to probucol treatment.
To determine whether the impaired response in glucocor-
ticoid secretion to LPS due to probucol feeding was phys-
iologically relevant in terms of the downstream glucocorti-
coid effects, the relative expression level of glucocorticoid
receptor-responsive genes involved in inflammation was
examined. Four hours after LPS exposure, proinflammatory
cytokine IL-6 and TNF mRNA expression was signifi-
cantly higher in livers of probucol-treated mice compared
with control mice (P  0.05 for both), whereas that of the
activated macrophage marker MARCO (macrophage recep-
tor with collagenous domain) did not differ between the two
groups of mice (Fig. 5A). In parallel with the observed
higher hepatic TNF mRNA expression level, the LPS-
induced TNF level in plasma was significantly increased in
probucol-treated mice (area under the curve: 498 	 68 vs.
263 	 28, P  0.012; Fig. 5B). Combined, these findings
suggest that a probucol-mediated reduction in plasma li-
poprotein levels is associated with adrenal glucocorticoid
insufficiency due to a lack of substrate availability, which is
paralleled by a lower hepatic glucocorticoid receptor activ-
ity and an enhanced susceptibility to endotoxemia.
To prove that cholesterol is actually acquired from plasma
lipoproteins by the adrenals under conditions of high steroido-
genic pressure, the uptake of 3H-labeled HDL cholesteryl ether
([3H]HDL-CEt) was determined under “basal” and LPS-in-
duced “stress” conditions. As shown in Fig. 6, a relatively high
uptake of [3H]HDL-CEt per microgram of tissue was detected
in the adrenals and liver of wild-type mice under basal condi-
tions. This was to be expected since both the liver and adrenals
express high mRNA levels of the HDL receptor SR-BI (1). As
Fig. 4. A: the effect of probucol treatment on
the corticosterone response to a lipopolysac-
charide (LPS) challenge. Mice that were fed
a regular chow diet supplemented with () or
without 0.25% probucol (Œ) were injected
with 50 g/kg LPS, and at the indicated
times blood was drawn for analysis of plasma
corticosterone levels. B: adrenal relative
mRNA expression levels of SR-BI, the
LDLR, HMGCR, HSL, and ACAT1 under
LPS-induced “stress” conditions. Gene ex-
pression levels were determined in adrenals
from probucol-fed (filled bars) and control
mice (open bars) 4 h after a LPS (50 g/kg)
challenge. Data represent means 
 SE of 5
mice. *P  0.05 and ***P  0.001 com-
pared with controls.
Fig. 5. A: the effect of probucol treatment on
the hepatic relative mRNA expression level
of IL-6, TNF, and the activated macro-
phage marker MARCO (macrophage recep-
tor with collagenous domain) under LPS-
induced stress conditions. Gene expression
levels were determined in livers from probu-
col-fed (filled bars) and control mice (open
bars) 4 h after a LPS (50 g/kg) challenge.
B: the plasma TNF response to a LPS
challenge in mice that were fed a regular
chow diet supplemented with () or without
0.25% probucol (Œ). Data represent means 

SE of 5 mice. *P  0.05 and **P  0.01
compared with controls.
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anticipated from in vitro studies showing that LPS decreases
the expression of SR-BI and the uptake of HDL in human and
mouse macrophages (3), the uptake of [3H]HDL-CEt was
decreased by LPS in the macrophage-rich tissue spleen
(33%, P  0.001; Fig. 6). Importantly, in accordance with a
prominent role for lipoproteins in adrenal steroidogenesis, the
uptake of [3H]HDL-CEt was stimulated specifically in the
adrenals (
37%, P  0.006; Fig. 6) in response to an increase
in steroidogenic pressure upon LPS injection. In contrast, no
change in the uptake of [3H]HDL-CEt by the liver was
detected, which argues against a nonspecific effect of LPS
on the cellular uptake of HDL-associated cholesteryl esters
via SR-BI.
DISCUSSION
Although in vitro studies have indicated that optimal adrenal
steroidogenesis is dependent on both de novo synthesis of
cholesterol and the catabolism of intracellular stored cho-
lesteryl esters, it is conceivable that cholesterol derived from
plasma lipoproteins makes a large contribution to the pool of
cholesterol used for steroid hormone synthesis. In the current
study, we have studied the effect of plasma lipoprotein deple-
tion by the lipid-lowering drug probucol on adrenal steroido-
genesis in mice. The transport of unesterified cholesterol from
the outer mitochondrial membrane to the inner membrane by
StAR is considered to be the rate-limiting step for glucocorti-
coid synthesis under basal conditions. Strikingly, we detected
a 44% lower plasma corticosterone level in probucol-treated
mice already in the basal setting. This suggests that low plasma
lipoprotein levels impair the basal adrenal glucocorticoid syn-
thesis rate probably because of a depletion of the intracellular
cholesterol pool used by the StAR protein. In accordance, we
observed that probucol-induced relative lipoprotein deficiency
was associated with a marked depletion of neutral lipids in the
zona fasciculata of the adrenal cortex, where glucocorticoid
synthesis is executed. Importantly, under these conditions the
adrenal mRNA expression of HMG-CoA reductase was in-
creased. De novo adrenal cholesterol synthesis was apparently
not able to compensate for a loss of lipoprotein-derived cho-
lesterol. Thus it can be suggested that plasma lipoproteins are
required to maintain optimal steroidogenesis in mice and prob-
ably are the major contributor to glucocorticoid synthesis under
basal conditions. Apolipoprotein A1 (apoA1)-knockout mice
that lack the main apolipoprotein constituent of HDL, apoA1,
exhibit a similarly lowered plasma HDL level, as detected in
the current study. In contrast, basal plasma corticosterone
levels are not different in apoA1-knockout mice compared with
their wild-type littermates (23). In addition, mice that are
deficient in the HDL receptor SR-BI and have an impaired
adrenal uptake of HDL-associated cholesteryl esters also do
not suffer from adrenal glucocorticoid insufficiency in the
basal state (9, 10). Thus it seems that a combination of
increased endogenous cholesterol synthesis and receptor-me-
diated uptake of lipoproteins other than HDL (i.e., LDL) can
overcome glucocorticoid insufficiency in these animals. Impor-
tantly, a defect in uptake of LDL via the LDL receptor alone
also does not affect adrenal steroidogenesis (15). In vitro
studies have indicated that both HDL and LDL can be utilized
as substrate for steroid synthesis in adrenocortical cells (2, 7, 8,
12). Combined, these findings suggest that both HDL and LDL
may be substrates actually used for basal steroidogenesis in
mice in vivo. However, the relative contribution of the two
different lipoproteins for steroid hormone synthesis under basal
conditions in wild-type mice remains to be established. Our
current studies also show that probucol-induced relative li-
poprotein deficiency is associated with a hampered protective
adrenal corticosterone response to an inflammatory stimulus
and an enhanced susceptibility to LPS-induced endotoxemia.
From our previous findings in SR-BI-knockout mice with and
without expression of the cholesteryl ester transfer protein
(10), it can be expected that the diminished glucocorticoid
stress response to LPS in probucol-treated mice can contribute
to the lowered plasma HDL but not LDL level. We now also
show that the uptake of HDL cholesteryl esters is increased
specifically in the adrenals but not other SR-BI-expressing
organs such as liver, indicating that cholesterol associated with
HDL is indeed used efficiently for adrenal steroidogenesis
under high steroidogenic pressure conditions (i.e., upon LPS
exposure) in mice. Probucol has potent antioxidant and anti-
inflammatory properties (16). However, probucol-treated mice
do still exhibit a higher TNF response upon exposure to a
sublethal dose of LPS. Glucocorticoids, via the action of the
nuclear glucocorticoid receptor, inhibit the expression of proin-
flammatory cytokines in immune cells such as dendritic cells
and macrophages (17, 22). Glucocorticoid insufficiency as a
result of adrenal removal (adrenalectomy) is associated with an
enhanced susceptibility to endotoxemia in mice (22). There-
fore, it is anticipated that the anti-inflammatory effect of
probucol is overruled by the proinflammatory effect of adrenal
glucocorticoid insufficiency induced by probucol in mice.
In a multivariate analysis in human patients with liver failure
and patients post-liver transplantation, low HDL cholesterol
levels were the only variable predictor of adrenal insufficiency
(19). Furthermore, in critically ill patients, in whom the need
for anti-inflammatory steroid hormone production is high, a
low plasma HDL cholesterol level was associated with an
impaired glucocorticoid (cortisol) response to synacthen stim-
ulation (26). This suggests that HDL is also required for
stress-induced adrenal glucocorticoid secretion in the human
Fig. 6. The effect of LPS on the tissue uptake of 3H-labeled HDL cholesteryl
ether ([3H]-HDL-CEt). One hour after a LPS (50 g/kg) challenge, mice were
given a bolus injection of [3H]-HDL-CEt. After 2 h, the radioactivity present
in the indicated organs was determined in LPS-injected (filled bars) and
control-injected mice (open bars) and expressed as a percent of the injected
dose (%ID)/g tissue. Data represent means 
 SE of 5 mice. **P  0.01 and
***P  0.001 compared with controls.
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situation, similar to what was observed for mice in the current
study. In humans, partial HDL deficiency or hypo--lipopro-
teinemia, defined as an age- and sex-adjusted plasma HDL
cholesterol concentration below the 10th percentile, can be
caused by a defect in several genes essentially involved in
HDL metabolism, including ATP-binding cassette transporter
A1, apoA1, lecithin-cholesterol acyltransferase, and phospho-
lipid transfer protein (11, 20). To further establish the impor-
tance of HDL for stress-induced adrenal glucocorticoid syn-
thesis in the human situation, it will be of interest to measure
the cortisol response to synacthen/ACTH stimulation in carri-
ers of functional mutations in these gene products.
In conclusion, we have shown that relative lipoprotein de-
ficiency in mice as a result of probucol feeding is associated
with decreased adrenal cortex cholesterol levels, a lower basal
and stress-induced plasma glucocorticoid level, and an in-
creased susceptibility to LPS-induced inflammation. There-
fore, it is suggested that plasma lipoproteins are required for
optimal adrenal steroidogenesis and protection against endo-
toxemia in mice.
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